Geographic Analysis of Cancer Patients' Residences at Delafontaine Hospital

NCT07206914 | Not Yet Recruiting

• 1 other identifier: 0116_ONCOLOGIE
• Study Type: observational
• Target: 300
• Locations: 1 country
• Sites: 1

Brief Summary

This study looks at where cancer patients treated at Delafontaine Hospital live and how far they have to travel for care. By mapping patients' home addresses (anonymized), the research will show how distance, transportation, and social factors affect access to cancer treatments and support services. The goal is to better understand inequalities in access to care and to improve patient support in the future.

Conditions

Neoplasms; Oncology Service; Health Services Accessibility; Health Inequalities; Residence Characteristics; Transportation of Patients

Outcome Measures

Primary Outcomes (1)

• Median travel time (minutes) from the patient's place of residence (IRIS centroid) to Delafontaine Hospital by the patient's usual mode of transport for oncology appointments.

  Assessed up to 5 years after first inclusion

Eligibility Criteria

• Sex: all
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Study participants will be selected from the population of patients treated for cancer in the oncology department of Delafontaine Hospital, located in Seine-Saint-Denis (93), France. This population includes adult patients receiving chemotherapy, radiotherapy, targeted therapies, immunotherapy, or supportive care as part of their cancer management. Since Delafontaine Hospital is a public hospital in a densely populated and socioeconomically diverse area of the Paris region, the patient population is expected to reflect a wide range of social, cultural, and economic backgrounds, including a high proportion of individuals from immigrant communities. This diversity provides a valuable context for studying inequalities in geographic accessibility to oncology care.

You may qualify if:

• \- Adult patients treated for cancer in the oncology department of Delafontaine Hospital since January 1, 2020.

You may not qualify if:

• \- Patients whose cancer treatment in the oncology department was completed before 2020.

Sponsors & Collaborators

• Centre Hospitalier de Saint-Denis: lead

Study Sites (1)

Centre Hospitalier de Saint-Denis

Saint-Denis, France, France

Location

MeSH Terms

Conditions

Neoplasms

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: September 26, 2025
• First Posted: October 3, 2025
• Study Start: October 15, 2025
• Primary Completion: April 15, 2026
• Study Completion: April 15, 2026
• Last Updated: October 3, 2025

Record last verified: 2025-09

Locations

FR (1)